N-acetyl cysteine reverses bio-behavioural changes induced by prenatal inflammation, adolescent methamphetamine exposure and combined challenges

Psychopharmacology

Volumn 235, Issue 1, 2018, Pages 351-368

  Swanepoel, Twanette ^a   Möller, Marisa ^a   Harvey, Brian Herbert ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Dual hit; Methamphetamine; N acetyl cysteine; Neurodevelopmental model; Prenatal infection; Psychosis

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; ACETYLCYSTEINE; DOPAMINE; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; METHAMPHETAMINE; MONOAMINE; NORADRENALIN; REACTIVE OXYGEN METABOLITE; SEROTONIN; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR; ANTIOXIDANT; BIOGENIC AMINE; CYTOKINE; SCAVENGER;

ADOLESCENT; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; INFLAMMATION; LIPID PEROXIDATION; MALE; NONHUMAN; NORADRENALIN BRAIN LEVEL; NOVEL OBJECT RECOGNITION TEST; OXIDATION REDUCTION REACTION; PRENATAL EXPOSURE; PREPULSE INHIBITION; PRIORITY JOURNAL; PROGENY; PROTEIN BLOOD LEVEL; PSYCHOSOCIAL WITHDRAWAL; RAT; SCHIZOPHRENIA; SENSORY GATING; SEROTONIN BRAIN LEVEL; SIGNAL TRANSDUCTION; SOCIAL INTERACTION; SOCIAL INTERACTION TEST; ANALYSIS OF VARIANCE; ANIMAL; ANIMAL BEHAVIOR; CHEMICALLY INDUCED; COMPLICATION; CORPUS STRIATUM; DRUG EFFECT; FEMALE; MEMORY; METABOLISM; PATTERN RECOGNITION; PREGNANCY; RECOGNITION; SOCIAL BEHAVIOR; SPRAGUE DAWLEY RAT; STARTLE REFLEX;

3,4-DIHYDROXYPHENYLACETIC ACID; ACETYLCYSTEINE; ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; BEHAVIOR, ANIMAL; BIOGENIC MONOAMINES; CORPUS STRIATUM; CYTOKINES; DOPAMINE; FEMALE; FORM PERCEPTION; FREE RADICAL SCAVENGERS; INFLAMMATION; LIPID PEROXIDATION; LIPOPOLYSACCHARIDES; MALE; MEMORY; METHAMPHETAMINE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PREPULSE INHIBITION; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECOGNITION (PSYCHOLOGY); REFLEX, STARTLE; SCHIZOPHRENIA; SEROTONIN; SOCIAL BEHAVIOR;

EID: 85033402519     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-017-4776-5     Document Type: Article

References (104)

1. Akdag SJ, Nestor PG, O'Donnell BF, Niznikiewicz MA, Shenton ME, McCarley RW (2003) The startle reflex in schizophrenia: habituation and personality correlates. Schizo Res 64:165–173. https://doi.org/10.1016/S0920-9964(03)00059-8
2. Alsene KM, Rajbhandari AK, Bakshi VP, Ramaker MJ (2011) Discrete forebrain neuronal networks supporting noradrenergic regulation of sensorimotor gating. Neuropsychopharmacology 36:1003–1014. https://doi.org/10.1038/npp.2010.238
3. Antunes M, Biala G (2012) The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process 13:93–110. https://doi.org/10.1007/s10339-011-0430-z
4. Arsenault D, St-Amour I, Cisbani G, Rousseau LS, Cicchetti F (2014) The different effects of LPS and poly I: C prenatal immune challenges on the behavior, development and inflammatory responses in pregnant mice and their offspring. Brain Behav Immun 38:77–90. https://doi.org/10.1016/j.bbi.2013.12.016
5. Baharnoori M, Bhardwaj SK, Srivastava LK (2013) Effect of maternal lipopolysaccharide administration on the development of dopaminergic receptors and transporter in the rat offspring. PLoS One 8. https://doi.org/10.1371/journal.pone.0054439
6. Basta-Kaim A, Budziszewska B, Regulska M, Leśkiewicz M, Kubera M, Lasoń W, Fijał K, Wȩdzony K, Gołembiowska K (2011) Prenatal lipopolysaccharide treatment enhances MK-801-induced psychotomimetic effects in rats. Pharmacol Biochem Behav 98:241–249. https://doi.org/10.1016/j.pbb.2010.12.026
7. Beloosesky R, Weiner Z, Ginsberg Y, Ross MG (2012) Maternal N-acetyl-cysteine (NAC) protects the rat fetal brain from inflammatory cytokine responses to lipopolysaccharide (LPS). J Matern Fetal Neonatal Med 25:1324–1328. https://doi.org/10.3109/14767058.2011.632793
8. Berk M, Copolov D, Dean O, Bush AI, Lu K, Schapkaitz I, Anderson-Hunt M, Jeavons S, Judd F, Katz F, Katz P, Ording-Jespersen S, Little J, Conus P, Cuenod M, Do KQ (2008) N-acetyl cysteine as a glutathione precursor for schizophrenia—a double-blind, randomized, placebo-controlled trial. Biol Psychiatry 64:361–368. https://doi.org/10.1016/j.biopsych.2008.03.004
9. Bitanihirwe BKY, Woo TUW (2011) Oxidative stress in schizophrenia: an integrated approach. Neurosci Biobehav Rev 35:878–893
10. Boksa P (2010) Effects of prenatal infection on brain development and behavior: a review of findings from animal models. Brain Behav Immun 24:881–897. https://doi.org/10.1016/j.bbi.2010.03.005
11. Borrell J, Vela JM, Arévalo-Martin A, Molina-Holgado E, Guaza C (2002) Prenatal immune challenge disrupts sensorimotor gating in adult rats: implications for the etiopathogenesis of schizophrenia. Neuropsychopharmacology 26:204–215. https://doi.org/10.1038/S0893-133X(01)00360-8
12. Brand SJ, Möller M, Harvey BH (2015) A review of biomarkers in mood and psychotic disorders: a dissection of clinical vs. preclinical correlates. Curr Neuropharmacol 13:324–368
13. Brecht M, Herbeck D (2014) Time to relapse following treatment for methamphetamine use: a long-term perspective on patterns and predictors. Drug Alcohol Depend 139:18–25
14. Brown AS, Derkits EJ (2010) Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry 167:261–280
15. Brown JM, Yamamoto BK (2003) Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress. Pharmacol Ther 99:45–53. https://doi.org/10.1016/S0163-7258(03)00052-4
16. Brunton LL, Chabner BA, Knollman BC (2011) Goodman and Gilman's The Pharmacological Basis of Therapeutics 12th Ed. McGraw-Hill Medical, New York
17. Calcagnetti DJ, Schechter MD (1992) Place conditioning reveals the rewarding aspect of social interaction in juvenile rats. Physiol Behav 51:667–672
18. Chen CK, Lin SK, Sham PC, Ball D, Loh EW, Hsiao CC, Chiang YL, Ree SC, Lee CH, Murray RM (2003) Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychol Med 33:1407–1414. https://doi.org/10.1017/S0033291703008353
19. Chen CK, Lin SK, Sham PC, Ball D, Loh e-W, Murray RM (2005) Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis. Am J Med Genet Neuropsychiatr Genet 136 B:87–91
20. Crumeyrolle-Arias M, Jaglin M, Bruneau A, Vancassel S, Cardona A, Daugé V, Naudon L, Rabot S (2014) Absence of the gut microbiota enhances anxiety-like behavior and neuroendocrine response to acute stress in rats. Psychoneuroendocrinology 42: 207-17
21. Dantzer R, O'Connor JC, Lawson MA, Kelley KW (2011) Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology 36:426–436. https://doi.org/10.1016/j.psyneuen.2010.09.012
22. Darke S, Kaye S, McKetin R, Duflou J (2008) Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev 27:253–262. https://doi.org/10.1080/09595230801923702
23. Davis J, Moylan S, Harvey BH, Maes M, Berk M (2014) Neuroprogression in schizophrenia: pathways underpinning clinical staging and therapeutic corollaries. Aust NZ J Psychiatry 48:512–529. https://doi.org/10.1177/0004867414533012
24. Davis J, Eyre H, Jacka FN, Dodd S, Dean O, McEwen S, Debnath M, McGrath J, Maes M, Amminger P, McGorry PD, Pantelis C, Berk M (2016) A review of vulnerability and risks for schizophrenia: beyond the two hit hypothesis. Neurosci Biobehav Rev 65:185–194
25. De Laurentiis A, Pisera D, Caruso C, Candolfi M, Mohn C, Rettori V, Seilicovich A (2002) Lipopolysaccharide-and tumor necrosis factor-α-induced changes in prolactin secretion and dopaminergic activity in the hypothalamic-pituitary axis. Neuroimmunomodulation 10:30–39
26. Debnath M, Venkatasubramanian G, Berk M (2015) Fetal programming of schizophrenia: select mechanisms. Neurosci Biobehav Rev 49:90–104. https://doi.org/10.1016/j.neubiorev.2014.12.003
27. Depino A (2015) Early prenatal exposure to LPS results in anxiety-and depression-related behaviors in adulthood. Neuroscience 299:56–65
28. Dinel A, Joffre C, Trifilieff P, Aubert A, Foury A, Le Ruyet P, Layé S (2014) Inflammation early in life is a vulnerability factor for emotional behavior at adolescence and for lipopolysaccharide-induced spatial memory and neurogenesis alteration at adulthood. J Neuroinflammation 11:155
29. Ferreira FF, Biojone C, Joca SRL, Guimarães FS (2008) Antidepressant-like effects of N-acetyl-L-cysteine in rats. Behav Pharmacol 19:747–750
30. File SE, Hyde JR (1978) Can social interaction be used to measure anxiety? Br J Pharmacol 62:19–24
31. File SE, Lippa AS, Beer B, Lippa MT (2005) Animal tests of anxiety. Current protocols in pharmacology / editorial board, S J Enna (editor-in-chief) et al ] Chapter 5:Unit 5.38.
32. Fleckenstein AE, Wilkins DG, Gibb JW, Hanson GR (1997) Interaction between hyperthermia and oxygen radical formation in the 5-hydroxytryptaminergic response to a single methamphetamine administration. J Pharmacol Exp Ther 283:281–285
33. Gaskin PLR (2014) Evaluation of novel dual-hit models of ‘schizophrenia-like’ symptoms in the rat (Doctoral dissertation, University of Nottingham)
34. Gaskin P, Alexander S, Fone K (2014) Neonatal phencyclidine administration and post-weaning social isolation as a dual-hit model of ‘schizophrenia-like’ behaviour in the rat. Psychopharmacol 231:2533–2545
35. Gemmel M, Rayen I, Lotus T, van Donkelaar E, Steinbusch HW, De Lacalle S, Kokras N, Dalla C, Pawluski JL (2016) Developmental fluoxetine and prenatal stress effects on serotonin, dopamine, and synaptophysin density in the PFC and hippocampus of offspring at weaning. Dev Psychobiol 58:315–327. https://doi.org/10.1002/dev.21372
36. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156:117
37. Gilabert-Juan J, Belles M, Saez AR, Carceller H, Zamarbide-Fores S, Moltó MD, Nacher J (2013) A “double hit” murine model for schizophrenia shows alterations in the structure and neurochemistry of the medial prefrontal cortex and the hippocampus. Neurobiol Dis 59:126–140. https://doi.org/10.1016/j.nbd.2013.07.008
38. Gonçalves J, Baptista S, Martins T, Milhazes N, Borges F, Ribeiro CF, Malva JO, Silva AP (2010) Methamphetamine-induced neuroinflammation and neuronal dysfunction in the mice hippocampus: preventive effect of indomethacin. Eur J Neurosci 31:315–326
39. Grace CE, Schaefer TL, Herring NR, Graham DL, Skelton MR, Gudelsky GA, Williams MT, Vorhees CV (2010) Effect of a neurotoxic dose regimen of (+)-methamphetamine on behavior, plasma corticosterone, and brain monoamines in adult C57BL/6 mice. Neurotoxicol Teratol 32:346–355 https://doi.org.nwulib.nwu.ac.za/10.1016/j.ntt.2010.01.006
40. Graciarena M, Depino AM, Pitossi FJ (2010) Prenatal inflammation impairs adult neurogenesis and memory related behavior through persistent hippocampal TGFß1 downregulation. Brain Behav Immun 24:1301–1309
41. Grant KM, LeVan TD, Wells SM, Gendelman HE, Li M, Stoltenberg SF, Carlo G, Bevins RA (2012) Methamphetamine-associated psychosis. J NeuroImmune Pharmacol 7:113–139. https://doi.org/10.1007/s11481-011-9288-1
42. Granholm AC, Zaman V, Godbee J, Smith M, Ramadan R, Umphlet C, Randall P, Bhat NR, Rohrer B, Middaugh LD, Boger HA (2011) Prenatal LPS increases inflammation in the substantia nigra of Gdnf heterozygous mice. Brain Pathol 21: 330-48
43. Grima G, Benz B, Parpura V, Cuénod M, Do KQ (2003) Dopamine-induced oxidative stress in neurons with glutathione deficit: implication for schizophrenia. Schizophr Res 62:213–224. https://doi.org/10.1016/S0920-9964(02)00405-X
44. Harvey L, Boksa P (2012) A stereological comparison of GAD67 and reelin expression in the hippocampal stratum oriens of offspring from two mouse models of maternal inflammation during pregnancy. Neuropharmacology 62:1767–1776. https://doi.org/10.1016/j.neuropharm.2011.11.022
45. Harvey L, Boksa P (2014) Additive effects of maternal iron deficiency and prenatal immune activation on adult behaviors in rat offspring. Brain Behav Immun 40:27–37 https://doi.org.nwulib.nwu.ac.za/10.1016/j.bbi.2014.06.005
46. Harvey BH, Brand L, Jeeva Z, Stein DJ (2006) Cortical/hippocampal monoamines, HPA-axis changes and aversive behavior following stress and restress in an animal model of post-traumatic stress disorder. Physiol Behav 87:881–890. https://doi.org/10.1016/j.physbeh.2006.01.033
47. Hastings TG (1995) Enzymatic oxidation of dopamine: the role of prostaglandin H synthase. J Neurochem 64:919–924
48. Hayashi I, Morishita Y, Imai K, Nakamura M, Nakachi K, Hayashi T (2007) High-throughput spectrophotometric assay of reactive oxygen species in serum. Mut Res Genet Toxicol Environ Mutagen 631:55–61. https://doi.org/10.1016/j.mrgentox.2007.04.006
49. Hornung JP (2003) The human raphe nuclei and the serotonergic system. J Chem Neuroanat 26:331–343
50. Howes OD, Kapur S (2014) A neurobiological hypothesis for the classification of schizophrenia: type A (hyperdopaminergic) and type B (normodopaminergic). Br J Psychiatry 205:1–3. https://doi.org/10.1192/bjp.bp.113.138578.
51. Howes OD, McCutcheon R, Owen MJ, Murray RM (2017) The role of genes, stress, and dopamine in the development of schizophrenia. Biol Psychiatry 81:9–20. https://doi.org/10.1016/j.biopsych.2016.07.014
52. Huckans M, Fuller BE, Chalker AL, Adams M, Loftis JM (2015) Plasma Inflammatory Factors Are Associated with Anxiety, Depression, and Cognitive Problems in Adults with and without Methamphetamine Dependence: An Exploratory Protein Array Study. Front Psychiatry 6:178
53. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG (2010) Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 8:e1000412
54. Lanté F, Guiramand J, De Ferreira M-J, Cambonie G, Aimar R, Cohen-Solal C, Vignes M, Barbanel G, Meunier J, Maurice T (2008) Late N-acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation. Hippocampus 18:602–609. https://doi.org/10.1002/hipo.20421
55. Laruelle M (2014) Schizophrenia: from dopaminergic to glutamatergic interventions. Curr Opin Pharmacol 14:97–102. https://doi.org/10.1016/j.coph.2014.01.001
56. Lieberman JA (1999) Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol Psychiatry 46:729–739
57. Limón-Pacheco J, Gonsebatt ME (2009) The role of antioxidants and antioxidant-related enzymes in protective responses to environmentally induced oxidative stress. Mutat Res Genet Toxicol Environ Mutagen 674:137–147
58. Loftis JM, Choi D, Hoffman W, Huckans MS (2011) Methamphetamine causes persistent immune dysregulation: a cross-species, translational report. Neurotox Res 20:59–68. https://doi.org/10.1007/s12640-010-9223-x
59. Lysaker PH, Salyers MP (2007) Anxiety symptoms in schizophrenia spectrum disorders: associations with social function, positive and negative symptoms, hope and trauma history. Acta Psychiatr Scand 116:290–298
60. Martínez-Cengotitabengoa M, Mac-Dowell KS, Leza JC, Micó JA, Fernandez M, Echevarría E, Sanjuan J, Elorza J, González-Pinto A (2012) Cognitive impairment is related to oxidative stress and chemokine levels in first psychotic episodes. Schizophr Res 137:66–72. https://doi.org/10.1016/j.schres.2012.03.004
61. McDonnell-Dowling K, Kelly JP (2017) The role of oxidative stress in methamphetamine-induced toxicity and sources of variation in the design of animal studies. Curr Neuropharmacol 15:300–314. https://doi.org/10.2174/1570159X14666160428110329
62. McGrath JJ, Feron FP, Burne TH, Mackay-Sim A, Eyles DW (2003) The neurodevelopmental hypothesis of schizophrenia: a review of recent developments. Ann Med 35:86–93
63. Meyer U (2013) Developmental neuroinflammation and schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry 42:20–34
64. Meyer U, Schwendener S, Feldon J, Yee BK (2006) Prenatal and postnatal maternal contributions in the infection model of schizophrenia. Exp Brain Res 173:243–257. https://doi.org/10.1007/s00221-006-0419-5
65. Meyer U, Feldon J, Yee BK (2009) A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. Schizophr Bull 35:959–972. https://doi.org/10.1093/schbul/sbn022
66. Meyer-Lindenberg A, Miletich RS, Kohn PD, Esposito G, Carson RE, Quarantelli M, Weinberger DR, Berman KF (2002) Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat Neurosci 5:267–271. https://doi.org/10.1038/nn804
67. Millan MJ (2003) The neurobiology and control of anxious states. Prog Neurobiol 70:83–244
68. Möller M, Harvey BH, Du Preez JL, Emsley R (2011) Isolation rearing-induced deficits in sensorimotor gating and social interaction in rats are related to cortico-striatal oxidative stress, and reversed by sub-chronic clozapine administration. Eur Neuropsychopharmacol 21:471–483. https://doi.org/10.1016/j.euroneuro.2010.09.006
69. Möller M, Du Preez JL, Viljoen FP, Berk M, Emsley R, Harvey BH (2013a) Social isolation rearing induces mitochondrial, immunological, neurochemical and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine. Brain Behav Immun 30:156–167 https://doi.org.nwulib.nwu.ac.za/10.1016/j.bbi.2012.12.011
70. Möller M, Du Preez JL, Viljoen FP, Berk M, Harvey BH (2013b) N-acetyl cysteine reverses social isolation rearing induced changes in cortico-striatal monoamines in rats. Metab Brain Dis 28:687–696
71. Möller M, Swanepoel T, Harvey BH (2015) Neurodevelopmental animal models reveal the convergent role of neurotransmitter systems, inflammation, and oxidative stress as biomarkers of schizophrenia: implications for novel drug development. ACS Chem Neurosci 6:987–1016. https://doi.org/10.1021/cn5003368
72. Montoya A, Bruins R, Katzman MA, Blier P (2016) The noradrenergic paradox: implications in the management of depression and anxiety. Neuropsychiatr Dis Treat 12:541
73. Mousavi SG, Sharbafchi MR, Peykanpour M, Sichani NK, Maracy M (2015) The efficacy of N-acetylcysteine in the treatment of methamphetamine dependence: a double-blind controlled, crossover study. Arch Iran Med 18:28
74. Mouton M, Harvey BH, Cockeran M, Brink CB (2016) The long-term effects of methamphetamine exposure during pre-adolescence on depressive-like behaviour in a genetic animal model of depression. Met Brain Dis 31:63–74. https://doi.org/10.1007/s11011-015-9765-y
75. Murray RM, Lewis SW (1987) Is schizophrenia a neurodevelopmental disorder? Br Med J 295:681–682
76. Nishijima K, Kashiwa A, Hashimoto A, Iwama H, Umino A, Nishikawa T (1996) Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo dialysis. Synapse 22:304–312
77. Ohyama K, Sano T, Toyoda H (2004) Predominant contribution of IFN-β expression to apoptosis induction in human uterine cervical fibroblast cells by influenza-virus infection. Biol Pharm Bull 27:1750–1757. https://doi.org/10.1248/bpb.27.1750
78. Panenka WJ, Procyshyn RM, MacEwan GW, Flynn SW, Honer WG, Barr AM, Lecomte T (2012) Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings. Drug Alcohol Depend. https://doi.org/10.1016/j.drugalcdep.2012.11.016
79. Paxinos G, Watson CR, Emson PC (1980) AChE-stained horizontal sections of the rat brain in stereotaxic coordinates. J Neurosci Methods 3:129–149
80. Pelletier M, Achim AM, Montoya A, Lal S, Lepage M (2005) Cognitive and clinical moderators of recognition memory in schizophrenia: a meta-analysis. Schizophr Res 74:233–252
81. Rajagopal L, W Massey B, Huang M, Oyamada Y, Y Meltzer H (2014) The novel object recognition test in rodents in relation to cognitive impairment in schizophrenia. Curr Pharm Des 20:5104–5114
82. Rajasekaran A, Venkatasubramanian G, Berk M, Debnath M (2015) Review: mitochondrial dysfunction in schizophrenia: pathways, mechanisms and implications. Neurosci Biobehav Rev 48:10–21. https://doi.org/10.1016/j.neubiorev.2014.11.005.
83. Rico JLR, Ferraz DB, Ramalho-Pinto F, Morato S (2010) Research report: neonatal exposure to LPS leads to heightened exploratory activity in adolescent rats. Behav Brain Res 215:102–109. https://doi.org/10.1016/j.bbr.2010.07.001.
84. Rogers J, De Santis S, See R (2008) Extended methamphetamine self-administration enhances reinstatement of drug seeking and impairs novel object recognition in rats. Psychopharmacology 199:615
85. Ross CA, Margolis RL, Reading SAJ, Pletnikov M, Coyle JT (2006) Review: neurobiology of schizophrenia. Neuron 52:139–153. https://doi.org/10.1016/j.neuron.2006.09.015
86. Santos P, Herrmann AP, Benvenutti R, Noetzold G, Giongo F, Gama CS, Piato AL, Elisabetsky E (2017) Anxiolytic properties of N-acetylcysteine in mice. Behav Brain Res 317:461–469
87. Sara SJ (2009) The locus coeruleus and noradrenergic modulation of cognition. Nat Rev Neurosci 10:211–223. https://doi.org/10.1038/nrn2573
88. Semple BD, Blomgren K, Gimlin K, Ferriero DM, Noble-Haeusslein LJ (2013) Brain development in rodents and humans: identifying benchmarks of maturation and vulnerability to injury across species. Prog Neurobiol 106:1–16
89. Shivalingappa PC, Jin H, Anantharam V, Kanthasamy A, Kanthasamy A (2012) N-acetyl cysteine protects against methamphetamine-induced dopaminergic neurodegeneration via modulation of redox status and autophagy in dopaminergic cells. Parkinson’s Disease
90. Strauss L, Brink CB, Möller M, Stein DJ, Harvey BH (2014) Late-life effects of chronic methamphetamine exposure during puberty on behaviour and corticostriatal mono-amines in social isolation-reared rats. Dev Neurosci 36:18–28
91. Tanaka M, Yoshida M, Emoto H, Ishii H (2000) Noradrenaline systems in the hypothalamus, amygdala and locus coeruleus are involved in the provocation of anxiety: basic studies. Eur J Pharmacol 405:397–406. https://doi.org/10.1016/S0014-2999(00)00569-0
92. Tandon R, Nasrallah HA, Keshavan MS (2009) Schizophrenia, “just the facts” 4. Clinical features and conceptualization. Schizophr Res 110:1–23. https://doi.org/10.1016/j.schres.2009.03.005
93. Temmingh H, Stein DJ (2015) Anxiety in patients with schizophrenia: epidemiology and management. CNS drugs 29:819–832
94. 1 receptor binding in rats. Neuroscience 165:492–499. https://doi.org/10.1016/j.neuroscience.2009.10.039
95. 2C-adrenoceptor antagonist, ORM-10921, has antipsychotic-like effects in social isolation reared rats and bolsters the response to haloperidol. Prog Neuro-Psychopharmacol Biol Psychiatry 71:108–116
96. 2C-adrenoceptor in cognition, depression, and schizophrenia—new developments and future perspective. Front Psychiatry 8:144. https://doi.org/10.3389/fpsyt.2017.00144
97. Velakoulis D, Wood SJ, McGorry PD, Pantelis C (2000) Evidence for progression of brain structural abnormalities in schizophrenia: beyond the neurodevelopmental model. Aust N Z J Psychiatry 34:S113–S126
98. Weinberger DR (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660–669
99. Wischhof L, Irrsack E, Osorio C, Koch M (2015) Prenatal LPS-exposure—a neurodevelopmental rat model of schizophrenia—differentially affects cognitive functions, myelination and parvalbumin expression in male and female offspring. Prog Neuro-Psychopharmacol Biol Psychiatry 57:17–30 https://doi.org.nwulib.nwu.ac.za/10.1016/j.pnpbp.2014.10.004
100. Wongwitdecha N, Marsden CA (1996) Social isolation increases aggressive behaviour and alters the effects of diazepam in the rat social interaction test. Behav Brain Res 75:27–32. https://doi.org/10.1016/0166-4328(96)00181-7
101. Yamamoto K, Hornykiewicz O (2004) Review article: proposal for a noradrenaline hypothesis of schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry 28:913–922. https://doi.org/10.1016/j.pnpbp.2004.05.033.
102. Yamamoto BK, Moszczynska A, Gudelsky GA (2010) Amphetamine toxicities: classical and emerging mechanisms. Ann N Y Acad Sci 1187:101–121
103. Zhang M, He L, Wan C, Zhao Z (2010) A meta-analysis of oxidative stress markers in schizophrenia. Sci China Life Sci 53:112–124. https://doi.org/10.1007/s11427-010-0013-8
104. Zhu Y, Carvey PM, Ling Z (2007) Altered glutathione homeostasis in animals prenatally exposed to lipopolysaccharide. Neurochem Int 50:671–680. https://doi.org/10.1016/j.neuint.2006.12.013